메뉴 건너뛰기




Volumn 38, Issue 6, 2008, Pages 432-437

A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: A report from the gastrointestinal Oncology group of the Japan clinical oncology group, JCOG 9207 trial

(14)  Hamaguchi, Tetsuya a   Shirao, Kuniaki a,k   Yamamichi, Noboru b   Hyodo, Ichinosuke c   Koizumi, Wasaburo d   Seki, Shigeki e   Imamura, Tetsuri f   Honma, Hisanobu g   Ohtsu, Atsushi h   Boku, Narikazu h   Mukai, Toshikazu i   Yamamoto, Seiichiro j   Fukuda, Haruhiko j   Yoshida, Shigeaki h  


Author keywords

5 fluorouracil; Gastric cancer; Methotrexate; Second line chemotherapy

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; VITAMIN B COMPLEX;

EID: 46349091798     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn043     Document Type: Article
Times cited : (18)

References (21)
  • 1
    • 47049093923 scopus 로고    scopus 로고
    • Statistics of Cancer, National Cancer Center, Japan
    • Statistics of Cancer. Center for Information Services. National Cancer Center, Japan, http://ganjoho.ncc.go.jp/public/statistics/pub/ update.html.
    • Center for Information Services
  • 2
    • 0027217474 scopus 로고
    • Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
    • Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993:72:37-41.
    • (1993) Cancer , vol.72 , pp. 37-41
    • Murad, A.M.1    Santiago, F.F.2    Petroianu, A.3    Rocha, P.R.4    Rodrigues, M.A.5    Rausch, M.6
  • 3
    • 0028006253 scopus 로고
    • Initial or delayed chemotherapy with best supportive care in advanced gastric cancer
    • Glimelius B, Hoffman K, Haglund U, Nyren O, Sjoden PO. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 1994:5:189-90.
    • (1994) Ann Oncol , vol.5 , pp. 189-190
    • Glimelius, B.1    Hoffman, K.2    Haglund, U.3    Nyren, O.4    Sjoden, P.O.5
  • 4
    • 0028959887 scopus 로고
    • Randomized comparison of fluorouracill, epidoxorubicin and methotrexate (FEMTX) plus best supportive care alone in patients with non-resectable gastric cancer
    • Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of fluorouracill, epidoxorubicin and methotrexate (FEMTX) plus best supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-91.
    • (1995) Br J Cancer , vol.71 , pp. 587-591
    • Pyrhonen, S.1    Kuitunen, T.2    Nyandoto, P.3    Kouri, M.4
  • 5
    • 0003859172 scopus 로고
    • 5-Fluorouracil-methotrexate synergy: Enhancement of 5-fluorodeoxyuridylate binding to thymidylate synthase by dihydropteroylpolyglutamates
    • Fernandes DJ, Bertino JR. 5-Fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyuridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. Proc Natl Acad Sci USA 1980;77:5663-7.
    • (1980) Proc Natl Acad Sci USA , vol.77 , pp. 5663-5667
    • Fernandes, D.J.1    Bertino, J.R.2
  • 6
    • 0018700143 scopus 로고
    • Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism
    • Cadman E, Heimer R, Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism. Science 1979;205:1135-7.
    • (1979) Science , vol.205 , pp. 1135-1137
    • Cadman, E.1    Heimer, R.2    Davis, L.3
  • 7
    • 0024414365 scopus 로고
    • Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial
    • Nordic Gastrointestinal Tumor Adjuvant Therapy Group
    • Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial. J Clin Oncol 1989;7:1437-46.
    • (1989) J Clin Oncol , vol.7 , pp. 1437-1446
  • 8
    • 0028219974 scopus 로고
    • Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer
    • Advanced Colorectal Cancer Meta-Analysis Project
    • Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 1994; 12:960-9
    • (1994) J Clin Oncol , vol.12 , pp. 960-969
  • 10
  • 11
    • 0024433274 scopus 로고
    • Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer
    • Sasaki T, Ota K, Ibayashi J, Sakata Y, Matsuoka T, Ishikawa M et al. Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer. Jpn J Cancer Chemother 1989; 16:2545-55.
    • (1989) Jpn J Cancer Chemother , vol.16 , pp. 2545-2555
    • Sasaki, T.1    Ota, K.2    Ibayashi, J.3    Sakata, Y.4    Matsuoka, T.5    Ishikawa, M.6
  • 12
    • 0003252333 scopus 로고
    • Response assessment of chemotherapy for gastric carcinoma
    • Japanese Research Society for Gastric Cancer, 1st edn Tokyo, Kanchara
    • Japanese Research Society for Gastric Cancer. Response assessment of chemotherapy for gastric carcinoma. Japanese Classification of Gastric Carcinoma. 1st edn Tokyo, Kanchara, 1995,90-104.
    • (1995) Japanese Classification of Gastric Carcinoma , pp. 90-104
  • 13
    • 17444454475 scopus 로고
    • Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group
    • Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K et al. Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 1993;23:250-7.
    • (1993) Jpn J Clin Oncol , vol.23 , pp. 250-257
    • Tobinai, K.1    Kohno, A.2    Shimada, Y.3    Watanabe, T.4    Tamura, T.5    Takeyama, K.6
  • 14
    • 0019969601 scopus 로고
    • Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer
    • Cocconi G, DeLisi V, Di Blasio B. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cancer Treatment Rep 1982; 56:1263-6.
    • (1982) Cancer Treatment Rep , vol.56 , pp. 1263-1266
    • Cocconi, G.1    DeLisi, V.2    Di Blasio, B.3
  • 15
    • 84944367593 scopus 로고
    • A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin
    • Cullinan SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA 1985;253:2061-7.
    • (1985) JAMA , vol.253 , pp. 2061-2067
    • Cullinan, S.A.1    Moertel, C.G.2    Fleming, T.R.3    Rubin, J.R.4    Krook, J.E.5    Everson, L.K.6
  • 16
    • 0027198871 scopus 로고
    • A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer
    • Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC et al. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 1993;71:3813-8.
    • (1993) Cancer , vol.71 , pp. 3813-3818
    • Kim, N.K.1    Park, Y.S.2    Heo, D.S.3    Suh, C.4    Kim, S.Y.5    Park, K.C.6
  • 17
    • 18744373000 scopus 로고    scopus 로고
    • Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
    • Ohta J A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H et al. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol 2003;21:54-9.
    • (2003) J Clin Oncol , vol.21 , pp. 54-59
    • Ohta, J.A.1    Shimada, Y.2    Shirao, K.3    Boku, N.4    Hyodo, I.5    Saito, H.6
  • 18
    • 0031015454 scopus 로고    scopus 로고
    • Fluorouracil in colorectal cancer-a tale of two drugs: Implications for biochemical modulation
    • Sobrero AF, Aschele C, Bertino JR. Fluorouracil in colorectal cancer-a tale of two drugs: Implications for biochemical modulation. J Clin Oncol 1997;15:368-81.
    • (1997) J Clin Oncol , vol.15 , pp. 368-381
    • Sobrero, A.F.1    Aschele, C.2    Bertino, J.R.3
  • 19
    • 0034830598 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel by threc-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
    • Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H et al. Phase II trial of paclitaxel by threc-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol 2001;12:1133-7.
    • (2001) Ann Oncol , vol.12 , pp. 1133-1137
    • Yamada, Y.1    Shirao, K.2    Ohtsu, A.3    Boku, N.4    Hyodo, I.5    Saitoh, H.6
  • 20
    • 0028276113 scopus 로고
    • Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group
    • Futatsuki K, Wakui A, Nakao I, Sakata Y, Kambe M, Shimada Y et al. Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group. Jpn J Cancer Chemother 1994;21:1033-8.
    • (1994) Jpn J Cancer Chemother , vol.21 , pp. 1033-1038
    • Futatsuki, K.1    Wakui, A.2    Nakao, I.3    Sakata, Y.4    Kambe, M.5    Shimada, Y.6
  • 21
    • 6044256382 scopus 로고    scopus 로고
    • Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: A report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial
    • Yamao T, Shimada Y, Shirao K, Ohtsu A, Ikeda N, Hyodo I et al. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: A report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Jpn J Clin Oncol. 2004;34:316-22.
    • (2004) Jpn J Clin Oncol , vol.34 , pp. 316-322
    • Yamao, T.1    Shimada, Y.2    Shirao, K.3    Ohtsu, A.4    Ikeda, N.5    Hyodo, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.